Status:
NOT_YET_RECRUITING
Developing a Whole-body MRI and Diffusion-weighted Imaging State-of-the-art Protocol: a Pilot Study
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Collaborating Sponsors:
GE Healthcare
Conditions:
Whole Body Imaging
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Whole-body magnetic resonance imaging (WB-MRI) is a non-ionizing imaging method that can provide WB coverage using essential imaging contrasts with the possibility to include sequences focusing in spe...
Eligibility Criteria
Inclusion
- Age ≥18 years old;
- Patients with diagnosis of multiple myeloma, lymphoma, lung, prostate, breast, colorectal and gynecologic cancers;
- Patients with genetic syndromes responsible for an increased predisposition to neoplasms (e.g. Li Fraumeni syndrome);
- Signed written informed consent to personal data treatment for research purposes
Exclusion
- Age \<18 years old;
- Refusal to sign the written informed consent to personal data treatment for research purposes.
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06533189
Start Date
September 1 2024
End Date
February 28 2026
Last Update
August 1 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Radiologia
Roma, Italy, 00168
2
Advanced Radiology Center
Rome, Italy, 00168